Caroline E. Lyon
University of Vermont(US)
Publications by Year
Research Areas
Vibrio bacteria research studies, Escherichia coli research studies, Viral gastroenteritis research and epidemiology, Salmonella and Campylobacter epidemiology, Cardiac Health and Mental Health
Most-Cited Works
- → Aerobic Capacity in Patients Entering Cardiac Rehabilitation(2006)203 cited
- → Robust and Balanced Immune Responses to All 4 Dengue Virus Serotypes Following Administration of a Single Dose of a Live Attenuated Tetravalent Dengue Vaccine to Healthy, Flavivirus-Naive Adults(2015)196 cited
- → Single-dose Live Oral Cholera Vaccine CVD 103-HgR Protects Against Human Experimental Infection WithVibrio choleraeO1 El Tor(2016)194 cited
- → Campylobacter jejuniStrain CG8421: A Refined Model for the Study of Campylobacteriosis and Evaluation ofCampylobacterVaccines in Human Subjects(2009)45 cited
- → Lack of Homologous Protection Against Campylobacter jejuni CG8421 in a Human Challenge Model(2013)40 cited
- → In a randomized, double-blinded, placebo-controlled trial, the single oral dose typhoid vaccine, M01ZH09, is safe and immunogenic at doses up to 1.7×1010 colony-forming units(2010)37 cited
- → Outcomes and Adverse Events Among Patients With Implantable Cardiac Defibrillators in Cardiac Rehabilitation(2009)36 cited
- → Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers(2018)36 cited
- → Lipopolysaccharide-specific memory B cell responses to an attenuated live cholera vaccine are associated with protection against Vibrio cholerae infection(2018)28 cited
- → The Live Attenuated Cholera Vaccine CVD 103-HgR Primes Responses to the Toxin-Coregulated Pilus Antigen TcpA in Subjects Challenged with Wild-Type Vibrio cholerae(2016)20 cited